Stockreport

Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS is among the 10 Fastest Growing NASDAQ Stocks to Buy Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (T [Read more]